A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC). (Q51286641)

From Wikidata
Jump to navigation Jump to search
scientific article published on 20 December 2012
edit
Language Label Description Also known as
English
A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC).
scientific article published on 20 December 2012

    Statements

    A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC) (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit